Skip Navigation Links
SEARCH  



 
Bookmark and Share
Pregene and Dr. Reddy’s Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
Shenzhen Pregene Biopharma and Dr. Reddy's Laboratories announce a license agreement whereby Dr Reddy's will acquire the exclusive rights in the Republic of India for PRG1801, an anti-BCMA CAR-T cell therapy injection based on single...

Full "IntellAsia: Resources" article




Disclaimer | Terms Of Use And Privacy Statement


© Metals News. All rights reserved.